SlideShare a Scribd company logo
presentation tilte
Text specific for subtitle
19.07.2010
Centro Nacional de Análisis Genómico
Introduction to Meeting
NGS and the molecular basis of
disease: a practical view.
Vall d’Hebron
Barcelona
Ivo Glynne Gut
11.02.2015
11th and 18th February 2015
Identification and analysis of sequence variants in
sequencing projects: fundamentals and tools
Short Course organised by the CNAG and VHIR
Sessions:
- Introduction to applications of next generation
sequencing to medical research
- Data analysis pipelines for NGS applications
- Interpretation of sequence variants in the biomedical
environment: what should we take into account
- Variant calling and somatic mutation identification and
prioritization on NGS data: an advanced overview
- Using and combining the different tools for predicting
the pathogenicity of sequence variants (PolyPhen,
SIFT, etc)
Overview of the Series
NGS and the molecular
basis of disease: a
practical view.
Ivo Gut, CNAG
Data analysis pipelines
for NGS applications
Sergi Beltran, CNAG
Interpretation of
sequence variants in
the clinical setting.
Xavier de la Cruz, VHIR
SESSION 1 (2h): FUNDAMENTALS
11. February 2015, 15:00-17:00
Data analysis pipelines
for NGS applications
Sophia Derdak, CNAG
Interpretation:
processing the output
of bioinformatics tools.
Casandra Riera, VHIR
SESSION 2 (2h): TOOLS
18. February 2015, 15:00-17:00
CNAG
The CNAG is a non-profit organization created on 2010 and integrated in the
Barcelona Science Park. It is funded by the Spanish Ministry of Economy and
Competitiveness and the Catalan Government through the Economy and
Knowledge Department and the Health Department (30M € initial funding, 2010-
2012). Competitive grants and contractual research with the private sector
provide additional funds.
Our Mission
To carry out large-scale projects in genome analysis that will lead to significant
improvements in people’s health and quality of life, in collaboration with the Catalan,
Spanish, European and International research and clinical community.
Our Vision
To be a large-scale, high quality sequence analysis center and to be a world reference
center for genomic analysis.
Director
Ivo Gut
1
Sequencing Department
Marta Gut
1
Biorepository (1)
Sample Preparation
(9)
Sequencing
Production (4)
Laboratory Support (3)
Single Cell
Genomics(2)
Bioinformatics Analysis
Sergi Beltran
1
Production
Bioinformatics (3)
Data Analysis (7)
Bioinformatics
Support (2)
Bioinformatics Development
Simon Heath
1
Statistical Genomics
(7)
Algorithm
Development (4)
Genome Biology
Marc Marti-Renom
1
Structural
Genomics (9)
Comparative
Genomics (1)
Applied Genomics
Ivo Gut
Biomedical
Genomics (4)
Genome Assembly
and Annotation (3)
Population
Genomics (1)
Programme
Manager
Mònica Bayés
2
Administrative
Support
3
Production Teams
ResearchTeams
CNAG Organigram
64 people 1 ICREA Research Professor
28 people funded or co-funded with personnel
grants or competitive projects
ICTS
The CNAG becomes part of the National Scientific and Technological Infrastructure Map (ICTS):
- Integrated Infrastructure for OMICS :
- Plataforma de Metabolómica del Centro de Ciencias Ómicas (COS, Lluis Arola).
- Centro Nacional de Análisis Genómico (CNAG, Ivo Gut)
- Requires >20% of competitive access. Since 2014 researchers with large scale projects are
required to submit an application that is reviewed by the Access Committee (constituted by CNAG
director, Elías Campo, Pere Puigdoménech and Ángel Carracedo).
The genomehenge
Sequencing capacity
• >1000 Gbases/day = 9-10 human genomes per day
at 30x coverage
Equipment
• 11 Illumina HiSeq2000/2500/1T
• 1 Illumina MiSeq
• 4 Illumina cBots
• 2 Oxford Nanopore Minions
• Caliper/Eppendorf liquid handling robotics
• Bull 1200 core cluster super computer
• Maxeler Data Flow Engine
• 25 Tflops
• 2.7 petabyte disc space
• Barcelona Supercomputing Center (10 x 10 Gb/s)
How we work – Our process
Biological
Resources
Sequencing Informatics
- Reception
- Quality control
- Conditioning
- Storage
- Sample Preparation
- Sequencing Production
- Methods Development
o Bioinformatic Analysis
o Bioinformatic Development
o Genome Biology
o Applied Genomics
LIMS + QC
BIOREPOSITORY LABORATORY SEQUENCING
QCANALYSISTRANSFER
LIMS
CNAG Workflow ISO9001
Sample preparation pipeline
Whole genome shotgun sequencing
no PCR, low input, FFPE, single cell
Whole exome capture sequencing
low input, FFPE
Custom capture sequencing
Amplicon sequencing
Genotyping-by-sequencing
RNA sequencing
polyA selection, Ribo Zero selection, directional,
low input, single cell
Whole genome bisulphite sequencing
regular and low input
Informatics Resources
Production Bioinformatics
• Primary run analysis and verification
• QC systems and LIMS
Analysis Production
• Alignment, variant calling and annotation
• Analysis and interpretation
Statistical Genomics
• DNA methylation pipeline
• RNA analysis pipeline
de novo Assembly and Annotation
• Pipeline for de novo assembly
• Pipeline for genome annotation
Algorithm Development
• Development and improvement of alignment and assembly methods - GEM
• Data compression
Structural Genomics
• Modelling of 3-d structure of genomes - HiC analysis
Comparative Genomics
Biomedical Genomics
• Advanced data mining
Population Genomics
Databases
• Storage and distribution of data
Variant Calling
Identification of genetic differences in comparison to a reference
(strict definition)
- Designs: Pedigree, trio, group, somatic
Variant analysis example: stepwise filtering
VCF
Filtering parameters
dbSNP
dbCNAG
Inheritance model
Functional annotation
Pedigree Multiple samples Somatic detection
Shared vs non-shared Fisher test allele counts
Variant analysis example: stepwise filtering
VCF
Filtering parameters
dbSNP
dbCNAG
Inheritance model
Functional annotation
Pedigree Multiple samples Somatic detection
Shared vs non-shared Fisher test allele counts
CNAG is a major contributor and driver in three large International Initiatives:
1.- International Cancer Genome Consortium (ICGC)
Spanish Project on Chronic Lymphocytic Leukaemia
French Project on Prostate Cancer
French Project on Ewing’s Sarcoma
2.- International Human Epigenome Consortium (IHEC)
EU-funded Project Blueprint
3.- International Rare Disorders Research Consortium (IRDiRC)
Spanish Project on Charcot-Marie-Tooth Disease
EU-funded C-Project on data analysis and coordination
What are our major projects?
83 Projects/18 Countries
Nature 464, 993-998 (15.04.2010)
Tumoral
Non-Tumoral
RNADNA methylationDNA
peripheral peritumoral
Whole-genome
bisulphite seq
Exome seq RNA seq
Whole-genome seq
short insert PE
Sampling structure
International Cancer Genome Consortium
The International Cancer Genome Consortium
is an international effort to establish a
comprehensive description of genomic,
transcriptomic and epigenomic changes in
50 different tumor types and/or subtypes
which are of clinical and societal importance
across the globe.
Spain’s contribution to the ICGC is on chronic
lymphocytic leukaemia (CLL).
FUNDING SOURCE: Ministerio de Ciencia e Innovación
COORDINATOR: Prof. Elias Campo, Hospital Clínic
Barcelona
DURATION: May 2009 – May 2014
PROJECT FUNDING: €10 million
XS Puente et al. Nature 000, 1-5 (2011) doi:10.1038/nature10113
Mutational and functional analysis of NOTCH1 in CLL
5. June 2011
• Sequencing of 105 CLL tumours
• Identification of 1246 somatic mutations in 1.100 genes
• 78 genes with mutations in more than one patient
• Mutated genes cluster in pathways
• Distinct mutations are associated with clinical classifications
• Mutations in the SF3B1 gene identifies a group of patients with more aggressive
disease
• SF3B1 encodes a subunit of the spliceosomal U2 small nuclear ribonucleoprotein
(snRNP)
V Quesada et al. Nature Genetics 44, 47-52 (2011) doi:10.1038/ng1032
Epigenetics
Sample Prep
Add unmethylated
lambda DNA
Bisulfite
conversion
qPCR check of
conversion
Sequencing
Fully convert
reads
Alignment
(GEM)
QC (mapping,
conversion)
Select uniquely mapping
read pairs
Make genotype and
methylation calls
Select sites with
genotype p.p. >=0.99
Select CpGs and non-
CpGs
Select homozygous CC
or GG sites
Region detection
and annotation
BS-Seq oxBS-Seq
Merge to obtain
estimates of mC and
hmC levels
BS-Sequencing Pipeline
Statistical Genomics Team (S. Heath)
• Distinct DNA methylomes of newborns and centenarians. Heyn
et al. 2012 (PNAS)
• Epigenomic analysis detects widespread gene-body DNA
hypomethylation in chronic lymphocytic leukemia. Kulis et al.
2012 (Nat. Genetics)
• Blueprint EU-FP7 project
BS-Sequencing applications - Statistical Genomics Team (S. Heath)
Proposed model for a different cell of origin of CLL subtypes
(U-CLL from naive-like B cells and M-CLL from memory-like B cells)
Naive
B cell
Leukemictransformation
Activation Proliferation Differentiation
Normal B cell differentiation
66%
CpGs in
common
Memory
B cell
Plasma
cell23,052 hypoM / 3,231 hyperM
U-CLL
M-CLL
4,607 hypoM
1,246 hyperM
3,265
diffM
M Kulis et al. Nature Genetics 44, 1236-1242 (2012) doi:10.1038/ng2443
Single-cell RNA-seq
Cell isolation
Library preparation
Sequencing
Data analysis
Single-cell isolation methods
• Laser capture micro-dissection (LCM)
• Manual micro-pipetting (ICSI-like)
• Fluorescent-activated cell sorting (FACS)
• Microfluidic methods
– C1 Single-cell AutoPrep System (Fluidigm)
– Droplet-based microfluidics
• Single-cell RNA-seq in context (in situ), no need for single-cell isolation
• C1 Single-cell AutoPrep System (Fluidigm)
Continuous-flow microfluidics
Small cells: 5-10µm
Medium cells: 10-17µm
Large cells: 17-25µm
www.fluidigm.com
Library preparation
Cell lysis
Reverse transcription:
1st strand synthesis
2nd strand synthesis
cDNA amplification
Addition of
adapters for
sequencing
Library amplification
SMART-seq
Image from www.clontech.com Ramsköld et al, Nature Biotech, 2012
Switching
Mechanism
At 5’ end of
RNA
Template
Based on MMLV RTase properties:
1- Terminal transferase activity
Adds non-templated Cs
2- Template switching activity
(improves full-length capture)
MMLV RT: Moloney murine leukemia
virus reverse transcriptase
(Oligo dT)
1
2
Scatter plots (pairwise comparisons)
Correlation is better for highly
expressed genes
Single cell 750 a,b,c excellent correlation
although different libraries
Worst correlation with
debris
Principal component analysis
Principal component analysis (- pool and debris)
MARS-seq
Jaitin et al, Science, 2014
Collaborators
27
93 94
116
2
10 11
3
0
20
40
60
80
100
120
140
2011 2012 2013 2014
Collaborators by sector
Public Private
3
20
31 2626
83
74
93
0
20
40
60
80
100
120
140
2011 2012 2013 2014
Collaborators by origin
International National
Sequencing applications and research area
2014 activity by sequencing application 2014 activity by research area
51,12%
21,75%
0,95%
26,19%
Cancer Genomics
Disease Gene Identification
Infectious Disease Genomics
Model-and Agro-Genomics
41,60%
25,08%
21,29%
9,13%
1,49% 0,84% 0,57%
WG-Seq Exome-Seq
RNA-Seq BS-Seq
Custom Capture-Seq ChIP-Seq
Genotyping by Seq
1st CNAG Call for Exome Sequencing in rare disorders – 2013/2014
The program has provided free-of-
charge Whole Exome Sequencing
and Bioinformatic analysis to the
selected projects.
 44 Applications received (941
exomes)
 23 Projects selected by an
External Selection Committee
(345 exomes)
 Confirmed causal variants in 3
families
 Putative causal variants in 19
families
How do we work with our collaborators?
• Collaboration from study design to paper writing
• Contact through the CNAG Project Manager (projectmanager-cnag@pcb.ub.es)
or Fatima Nuñez
• First point of discussion – advice on project
• Agreement on project
• Sample transfer using a standardized procedure (Lidia Agueda)
• Sample preparation and sequencing (Marta Gut)
• Data analysis (Sergi Beltran)
It is like Ballet, - because it looks easy,
everyone thinks it is easy.
26th February 2015
Auditori Antoni Caparrós
Parc Científic de Barcelona
Free online registration at:
www.pcb.ub.edu/cnagevents
Acknowledgements
Ivo Gut
Mònica Bayés
Berta Fusté
Diego Ravenda
Katia López
Anna Borrell
Marta Gut
Julie Blanc
Katja Kahlem
María Méndez-Lago
Lidia Agueda
Lidia Sevilla
Javier Gutiérrez
Aurora Padrón
Gloria Plaja
Marta López
Pili Herruzo
Bea Fontal
Ana González
Laetitia Casano
Amaya Alzu
Maite Rico
Caterina Mata
Amy Guillaumet
Nicolas Boulanger
Esther Lizano
Simon Heath
Sergi Beltran
Marc A. Marti-Renom
Tomas Marques
Jordi Camps
Jean-Rémi Trotta
Emanuele Raineri
Ron Schuyler
Angelika Merkel
Marc Dabad
Justin Whalley
Paolo Ribeca
Tyler Alioto
Leonor Frías
Santiago Marco
Lukasz Roguski
Marcos Fernández
Fernando Cruz
Anna Esteve
Davide Baú
François Serra
Sophia Derdak
Steven Laurie
Raul Tonda
Enric Serra
Francisco Martínez
Mike Goodstadt
Matt Ingham
Colin Kingswood
Raul Alcántara
Meritxell Oliva
Gian Andri Thun
Gustavo Rodriguez-Esteban
Miranda Stobbe
baldiri reixac, 4
08028, barcelona
spain
t +34 93 4020542
f +34 93 4037279
www.cnag.eu

More Related Content

What's hot

Errors and Limitaions of Next Generation Sequencing
Errors and Limitaions of Next Generation SequencingErrors and Limitaions of Next Generation Sequencing
Errors and Limitaions of Next Generation Sequencing
Nixon Mendez
 
Next Generation Sequencing and its Applications in Medical Research - Frances...
Next Generation Sequencing and its Applications in Medical Research - Frances...Next Generation Sequencing and its Applications in Medical Research - Frances...
Next Generation Sequencing and its Applications in Medical Research - Frances...
Sri Ambati
 
Aug2015 deanna church analytical validation
Aug2015 deanna church analytical validationAug2015 deanna church analytical validation
Aug2015 deanna church analytical validation
GenomeInABottle
 
Next generation sequencing in pharmacogenomics
Next generation sequencing in pharmacogenomicsNext generation sequencing in pharmacogenomics
Next generation sequencing in pharmacogenomicsDr. Gerry Higgins
 
NGS Applications II (UEB-UAT Bioinformatics Course - Session 2.1.3 - VHIR, Ba...
NGS Applications II (UEB-UAT Bioinformatics Course - Session 2.1.3 - VHIR, Ba...NGS Applications II (UEB-UAT Bioinformatics Course - Session 2.1.3 - VHIR, Ba...
NGS Applications II (UEB-UAT Bioinformatics Course - Session 2.1.3 - VHIR, Ba...
VHIR Vall d’Hebron Institut de Recerca
 
Listeria monocytogenes from population structure to genomic epidemiology
Listeria monocytogenes from population structure to genomic epidemiologyListeria monocytogenes from population structure to genomic epidemiology
Listeria monocytogenes from population structure to genomic epidemiology
European Centre for Disease Prevention and Control (ECDC)
 
Understanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assaysUnderstanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assays
Candy Smellie
 
20170209 ngs for_cancer_genomics_101
20170209 ngs for_cancer_genomics_10120170209 ngs for_cancer_genomics_101
20170209 ngs for_cancer_genomics_101
Ino de Bruijn
 
20160219 - S. De Toffol - Dal Sanger al NGS nello studio delle mutazioni BRCA
20160219 - S. De Toffol -  Dal Sanger al NGS nello studio delle mutazioni BRCA �20160219 - S. De Toffol -  Dal Sanger al NGS nello studio delle mutazioni BRCA �
20160219 - S. De Toffol - Dal Sanger al NGS nello studio delle mutazioni BRCA
Roberto Scarafia
 
Data Management for Quantitative Biology - Data sources (Next generation tech...
Data Management for Quantitative Biology - Data sources (Next generation tech...Data Management for Quantitative Biology - Data sources (Next generation tech...
Data Management for Quantitative Biology - Data sources (Next generation tech...
QBiC_Tue
 
Speeding up sequencing: Sequencing in an hour enables sample to answer in a w...
Speeding up sequencing: Sequencing in an hour enables sample to answer in a w...Speeding up sequencing: Sequencing in an hour enables sample to answer in a w...
Speeding up sequencing: Sequencing in an hour enables sample to answer in a w...
Thermo Fisher Scientific
 
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Nathan Olson
 
Bioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysisBioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysis
Despoina Kalfakakou
 
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Thermo Fisher Scientific
 
Metagenomics sequencing
Metagenomics sequencingMetagenomics sequencing
Metagenomics sequencing
cdgenomics525
 
Phylogenomic methods for comparative evolutionary biology - University Colleg...
Phylogenomic methods for comparative evolutionary biology - University Colleg...Phylogenomic methods for comparative evolutionary biology - University Colleg...
Phylogenomic methods for comparative evolutionary biology - University Colleg...
Joe Parker
 
140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposalGenomeInABottle
 
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
VHIR Vall d’Hebron Institut de Recerca
 

What's hot (20)

Errors and Limitaions of Next Generation Sequencing
Errors and Limitaions of Next Generation SequencingErrors and Limitaions of Next Generation Sequencing
Errors and Limitaions of Next Generation Sequencing
 
Next Generation Sequencing and its Applications in Medical Research - Frances...
Next Generation Sequencing and its Applications in Medical Research - Frances...Next Generation Sequencing and its Applications in Medical Research - Frances...
Next Generation Sequencing and its Applications in Medical Research - Frances...
 
Aug2015 deanna church analytical validation
Aug2015 deanna church analytical validationAug2015 deanna church analytical validation
Aug2015 deanna church analytical validation
 
Next generation sequencing in pharmacogenomics
Next generation sequencing in pharmacogenomicsNext generation sequencing in pharmacogenomics
Next generation sequencing in pharmacogenomics
 
NGS Applications II (UEB-UAT Bioinformatics Course - Session 2.1.3 - VHIR, Ba...
NGS Applications II (UEB-UAT Bioinformatics Course - Session 2.1.3 - VHIR, Ba...NGS Applications II (UEB-UAT Bioinformatics Course - Session 2.1.3 - VHIR, Ba...
NGS Applications II (UEB-UAT Bioinformatics Course - Session 2.1.3 - VHIR, Ba...
 
Listeria monocytogenes from population structure to genomic epidemiology
Listeria monocytogenes from population structure to genomic epidemiologyListeria monocytogenes from population structure to genomic epidemiology
Listeria monocytogenes from population structure to genomic epidemiology
 
Understanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assaysUnderstanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assays
 
20170209 ngs for_cancer_genomics_101
20170209 ngs for_cancer_genomics_10120170209 ngs for_cancer_genomics_101
20170209 ngs for_cancer_genomics_101
 
20160219 - S. De Toffol - Dal Sanger al NGS nello studio delle mutazioni BRCA
20160219 - S. De Toffol -  Dal Sanger al NGS nello studio delle mutazioni BRCA �20160219 - S. De Toffol -  Dal Sanger al NGS nello studio delle mutazioni BRCA �
20160219 - S. De Toffol - Dal Sanger al NGS nello studio delle mutazioni BRCA
 
Pattemore 2015
Pattemore 2015Pattemore 2015
Pattemore 2015
 
Data Management for Quantitative Biology - Data sources (Next generation tech...
Data Management for Quantitative Biology - Data sources (Next generation tech...Data Management for Quantitative Biology - Data sources (Next generation tech...
Data Management for Quantitative Biology - Data sources (Next generation tech...
 
Speeding up sequencing: Sequencing in an hour enables sample to answer in a w...
Speeding up sequencing: Sequencing in an hour enables sample to answer in a w...Speeding up sequencing: Sequencing in an hour enables sample to answer in a w...
Speeding up sequencing: Sequencing in an hour enables sample to answer in a w...
 
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
 
Bioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysisBioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysis
 
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
 
Metagenomics sequencing
Metagenomics sequencingMetagenomics sequencing
Metagenomics sequencing
 
Testing for Food Authenticity
Testing for Food AuthenticityTesting for Food Authenticity
Testing for Food Authenticity
 
Phylogenomic methods for comparative evolutionary biology - University Colleg...
Phylogenomic methods for comparative evolutionary biology - University Colleg...Phylogenomic methods for comparative evolutionary biology - University Colleg...
Phylogenomic methods for comparative evolutionary biology - University Colleg...
 
140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal
 
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
 

Viewers also liked

NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...
NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...
NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...
Vall d'Hebron Institute of Research (VHIR)
 
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focus
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focusAllogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focus
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focus
Vall d'Hebron Institute of Research (VHIR)
 
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ..."The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
Vall d'Hebron Institute of Research (VHIR)
 
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Vall d'Hebron Institute of Research (VHIR)
 
Indian contract act, 1872
Indian contract act, 1872Indian contract act, 1872
Indian contract act, 1872silky.bagga23
 
Тепловизионная диагностика частного дома
Тепловизионная диагностика частного домаТепловизионная диагностика частного дома
Тепловизионная диагностика частного дома
alexzaych
 
Are your medical office practices putting you at risk for a lawsuit?
Are your medical office practices putting you at risk for a lawsuit?Are your medical office practices putting you at risk for a lawsuit?
Are your medical office practices putting you at risk for a lawsuit?
gppcpa
 
Role of Companies in Horizon 2020 (David Rovirosa)
Role of Companies in Horizon 2020 (David Rovirosa)Role of Companies in Horizon 2020 (David Rovirosa)
Role of Companies in Horizon 2020 (David Rovirosa)
Vall d'Hebron Institute of Research (VHIR)
 
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...
Vall d'Hebron Institute of Research (VHIR)
 
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?
Vall d'Hebron Institute of Research (VHIR)
 
The Wnt–β-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancer
The Wnt–β-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancerThe Wnt–β-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancer
The Wnt–β-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancer
Vall d'Hebron Institute of Research (VHIR)
 
Richard horton, barcelona 2014
Richard horton, barcelona 2014Richard horton, barcelona 2014
Richard horton, barcelona 2014
Vall d'Hebron Institute of Research (VHIR)
 

Viewers also liked (20)

Mutual fund ppt
Mutual fund pptMutual fund ppt
Mutual fund ppt
 
NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...
NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...
NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...
 
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focus
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focusAllogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focus
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focus
 
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ..."The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
 
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
 
Indian contract act, 1872
Indian contract act, 1872Indian contract act, 1872
Indian contract act, 1872
 
Madhavi
MadhaviMadhavi
Madhavi
 
Mutual fund ppt
Mutual fund pptMutual fund ppt
Mutual fund ppt
 
Тепловизионная диагностика частного дома
Тепловизионная диагностика частного домаТепловизионная диагностика частного дома
Тепловизионная диагностика частного дома
 
Are your medical office practices putting you at risk for a lawsuit?
Are your medical office practices putting you at risk for a lawsuit?Are your medical office practices putting you at risk for a lawsuit?
Are your medical office practices putting you at risk for a lawsuit?
 
Role of Companies in Horizon 2020 (David Rovirosa)
Role of Companies in Horizon 2020 (David Rovirosa)Role of Companies in Horizon 2020 (David Rovirosa)
Role of Companies in Horizon 2020 (David Rovirosa)
 
Ifs unit 6
Ifs unit 6Ifs unit 6
Ifs unit 6
 
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...
 
Cheeseman6e ch11
Cheeseman6e ch11Cheeseman6e ch11
Cheeseman6e ch11
 
Facebook page
Facebook pageFacebook page
Facebook page
 
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?
 
The Wnt–β-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancer
The Wnt–β-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancerThe Wnt–β-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancer
The Wnt–β-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancer
 
Richard horton, barcelona 2014
Richard horton, barcelona 2014Richard horton, barcelona 2014
Richard horton, barcelona 2014
 
Mutual fund ppt
Mutual fund pptMutual fund ppt
Mutual fund ppt
 
Abortion
AbortionAbortion
Abortion
 

Similar to NGS and the molecular basis of disease: a practical view

Open data genomics_palermo_2017_ver03
Open data genomics_palermo_2017_ver03Open data genomics_palermo_2017_ver03
Open data genomics_palermo_2017_ver03
Neuro, McGill University
 
Shanghai University
Shanghai UniversityShanghai University
Shanghai University
dandandany
 
Center for Clinical Genomics and Personalized Medicine, Hungary
Center for Clinical Genomics and Personalized Medicine, HungaryCenter for Clinical Genomics and Personalized Medicine, Hungary
Center for Clinical Genomics and Personalized Medicine, Hungary
Balint L. Balint
 
PadminiNarayanan-Intro-2018.pptx
PadminiNarayanan-Intro-2018.pptxPadminiNarayanan-Intro-2018.pptx
PadminiNarayanan-Intro-2018.pptx
DESMONDEZIEKE1
 
Data sharing and analysis
Data sharing and analysisData sharing and analysis
Data sharing and analysis
EURORDIS Rare Diseases Europe
 
LIMS in Modern Molecular Pathology by Dr. Perry Maxwell
LIMS in Modern Molecular Pathology by Dr. Perry MaxwellLIMS in Modern Molecular Pathology by Dr. Perry Maxwell
LIMS in Modern Molecular Pathology by Dr. Perry Maxwell
Cirdan
 
SNOMED CT concept model for molecular pathology_final.pptx
SNOMED CT concept model for molecular pathology_final.pptxSNOMED CT concept model for molecular pathology_final.pptx
SNOMED CT concept model for molecular pathology_final.pptx
HariHaran685388
 
Forum on Personalized Medicine: Challenges for the next decade
Forum on Personalized Medicine: Challenges for the next decadeForum on Personalized Medicine: Challenges for the next decade
Forum on Personalized Medicine: Challenges for the next decade
Joaquin Dopazo
 
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...Intel IT Center
 
The Transforming Genetic Medicine Initiative (TGMI)
The Transforming Genetic Medicine Initiative (TGMI)The Transforming Genetic Medicine Initiative (TGMI)
The Transforming Genetic Medicine Initiative (TGMI)
Genome Reference Consortium
 
[DSC Europe 23][DigiHealth] Branka Zukic Big Data Personalized medicine
[DSC Europe 23][DigiHealth] Branka Zukic Big Data Personalized medicine[DSC Europe 23][DigiHealth] Branka Zukic Big Data Personalized medicine
[DSC Europe 23][DigiHealth] Branka Zukic Big Data Personalized medicine
DataScienceConferenc1
 
Bioinformatica 29-09-2011-t1-bioinformatics
Bioinformatica 29-09-2011-t1-bioinformaticsBioinformatica 29-09-2011-t1-bioinformatics
Bioinformatica 29-09-2011-t1-bioinformatics
Prof. Wim Van Criekinge
 
Trans disciplinary research is a must for excellence in science by Prof. Moha...
Trans disciplinary research is a must for excellence in science by Prof. Moha...Trans disciplinary research is a must for excellence in science by Prof. Moha...
Trans disciplinary research is a must for excellence in science by Prof. Moha...
Prof. Mohamed Labib Salem
 
Nov 2014 ouellette_windsor_icgc_final
Nov 2014 ouellette_windsor_icgc_finalNov 2014 ouellette_windsor_icgc_final
Nov 2014 ouellette_windsor_icgc_final
Neuro, McGill University
 
Biocuration activities for the International Cancer Genome Consortium (ICGC).
Biocuration activities for the International Cancer Genome Consortium (ICGC).Biocuration activities for the International Cancer Genome Consortium (ICGC).
Biocuration activities for the International Cancer Genome Consortium (ICGC).
Neuro, McGill University
 
New Generation Sequencing Technologies: an overview
New Generation Sequencing Technologies: an overviewNew Generation Sequencing Technologies: an overview
New Generation Sequencing Technologies: an overview
Paolo Dametto
 
PhenoMeNal: Large scale computing with medical metabolic phenotyping data
PhenoMeNal: Large scale computing with medical metabolic phenotyping dataPhenoMeNal: Large scale computing with medical metabolic phenotyping data
PhenoMeNal: Large scale computing with medical metabolic phenotyping data
Christoph Steinbeck
 
Overview of the commonly used sequencing platforms, bioinformatic search tool...
Overview of the commonly used sequencing platforms, bioinformatic search tool...Overview of the commonly used sequencing platforms, bioinformatic search tool...
Overview of the commonly used sequencing platforms, bioinformatic search tool...
OECD Environment
 
Grand round whsiao_may2015
Grand round whsiao_may2015Grand round whsiao_may2015
Grand round whsiao_may2015
IRIDA_community
 

Similar to NGS and the molecular basis of disease: a practical view (20)

Open data genomics_palermo_2017_ver03
Open data genomics_palermo_2017_ver03Open data genomics_palermo_2017_ver03
Open data genomics_palermo_2017_ver03
 
Shanghai University
Shanghai UniversityShanghai University
Shanghai University
 
Center for Clinical Genomics and Personalized Medicine, Hungary
Center for Clinical Genomics and Personalized Medicine, HungaryCenter for Clinical Genomics and Personalized Medicine, Hungary
Center for Clinical Genomics and Personalized Medicine, Hungary
 
PadminiNarayanan-Intro-2018.pptx
PadminiNarayanan-Intro-2018.pptxPadminiNarayanan-Intro-2018.pptx
PadminiNarayanan-Intro-2018.pptx
 
Data sharing and analysis
Data sharing and analysisData sharing and analysis
Data sharing and analysis
 
LIMS in Modern Molecular Pathology by Dr. Perry Maxwell
LIMS in Modern Molecular Pathology by Dr. Perry MaxwellLIMS in Modern Molecular Pathology by Dr. Perry Maxwell
LIMS in Modern Molecular Pathology by Dr. Perry Maxwell
 
SNOMED CT concept model for molecular pathology_final.pptx
SNOMED CT concept model for molecular pathology_final.pptxSNOMED CT concept model for molecular pathology_final.pptx
SNOMED CT concept model for molecular pathology_final.pptx
 
Forum on Personalized Medicine: Challenges for the next decade
Forum on Personalized Medicine: Challenges for the next decadeForum on Personalized Medicine: Challenges for the next decade
Forum on Personalized Medicine: Challenges for the next decade
 
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...
 
The Transforming Genetic Medicine Initiative (TGMI)
The Transforming Genetic Medicine Initiative (TGMI)The Transforming Genetic Medicine Initiative (TGMI)
The Transforming Genetic Medicine Initiative (TGMI)
 
[DSC Europe 23][DigiHealth] Branka Zukic Big Data Personalized medicine
[DSC Europe 23][DigiHealth] Branka Zukic Big Data Personalized medicine[DSC Europe 23][DigiHealth] Branka Zukic Big Data Personalized medicine
[DSC Europe 23][DigiHealth] Branka Zukic Big Data Personalized medicine
 
Bioinformatica 29-09-2011-t1-bioinformatics
Bioinformatica 29-09-2011-t1-bioinformaticsBioinformatica 29-09-2011-t1-bioinformatics
Bioinformatica 29-09-2011-t1-bioinformatics
 
Trans disciplinary research is a must for excellence in science by Prof. Moha...
Trans disciplinary research is a must for excellence in science by Prof. Moha...Trans disciplinary research is a must for excellence in science by Prof. Moha...
Trans disciplinary research is a must for excellence in science by Prof. Moha...
 
Nov 2014 ouellette_windsor_icgc_final
Nov 2014 ouellette_windsor_icgc_finalNov 2014 ouellette_windsor_icgc_final
Nov 2014 ouellette_windsor_icgc_final
 
Biocuration activities for the International Cancer Genome Consortium (ICGC).
Biocuration activities for the International Cancer Genome Consortium (ICGC).Biocuration activities for the International Cancer Genome Consortium (ICGC).
Biocuration activities for the International Cancer Genome Consortium (ICGC).
 
JALANov2000
JALANov2000JALANov2000
JALANov2000
 
New Generation Sequencing Technologies: an overview
New Generation Sequencing Technologies: an overviewNew Generation Sequencing Technologies: an overview
New Generation Sequencing Technologies: an overview
 
PhenoMeNal: Large scale computing with medical metabolic phenotyping data
PhenoMeNal: Large scale computing with medical metabolic phenotyping dataPhenoMeNal: Large scale computing with medical metabolic phenotyping data
PhenoMeNal: Large scale computing with medical metabolic phenotyping data
 
Overview of the commonly used sequencing platforms, bioinformatic search tool...
Overview of the commonly used sequencing platforms, bioinformatic search tool...Overview of the commonly used sequencing platforms, bioinformatic search tool...
Overview of the commonly used sequencing platforms, bioinformatic search tool...
 
Grand round whsiao_may2015
Grand round whsiao_may2015Grand round whsiao_may2015
Grand round whsiao_may2015
 

More from Vall d'Hebron Institute of Research (VHIR)

Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?
Vall d'Hebron Institute of Research (VHIR)
 
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu..."Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
Vall d'Hebron Institute of Research (VHIR)
 
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ..."Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
Vall d'Hebron Institute of Research (VHIR)
 
Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...
Vall d'Hebron Institute of Research (VHIR)
 
Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...
Vall d'Hebron Institute of Research (VHIR)
 
Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...
Vall d'Hebron Institute of Research (VHIR)
 
Data analysis pipelines for NGS applications
Data analysis pipelines for NGS applicationsData analysis pipelines for NGS applications
Data analysis pipelines for NGS applications
Vall d'Hebron Institute of Research (VHIR)
 
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemicsProf. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
Vall d'Hebron Institute of Research (VHIR)
 
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp..."Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
Vall d'Hebron Institute of Research (VHIR)
 
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ..."Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
Vall d'Hebron Institute of Research (VHIR)
 
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Vall d'Hebron Institute of Research (VHIR)
 
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
Vall d'Hebron Institute of Research (VHIR)
 
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To..."Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
Vall d'Hebron Institute of Research (VHIR)
 
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Vall d'Hebron Institute of Research (VHIR)
 
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ studyDr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
Vall d'Hebron Institute of Research (VHIR)
 
IRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhDIRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhD
Vall d'Hebron Institute of Research (VHIR)
 
Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...
Vall d'Hebron Institute of Research (VHIR)
 
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Vall d'Hebron Institute of Research (VHIR)
 
Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...
Vall d'Hebron Institute of Research (VHIR)
 
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Vall d'Hebron Institute of Research (VHIR)
 

More from Vall d'Hebron Institute of Research (VHIR) (20)

Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?
 
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu..."Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
 
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ..."Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
 
Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...
 
Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...
 
Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...
 
Data analysis pipelines for NGS applications
Data analysis pipelines for NGS applicationsData analysis pipelines for NGS applications
Data analysis pipelines for NGS applications
 
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemicsProf. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
 
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp..."Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
 
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ..."Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
 
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
 
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
 
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To..."Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
 
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
 
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ studyDr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
 
IRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhDIRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhD
 
Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...
 
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
 
Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...
 
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
 

Recently uploaded

Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 

Recently uploaded (20)

Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 

NGS and the molecular basis of disease: a practical view

  • 1. presentation tilte Text specific for subtitle 19.07.2010 Centro Nacional de Análisis Genómico Introduction to Meeting NGS and the molecular basis of disease: a practical view. Vall d’Hebron Barcelona Ivo Glynne Gut 11.02.2015
  • 2. 11th and 18th February 2015 Identification and analysis of sequence variants in sequencing projects: fundamentals and tools Short Course organised by the CNAG and VHIR Sessions: - Introduction to applications of next generation sequencing to medical research - Data analysis pipelines for NGS applications - Interpretation of sequence variants in the biomedical environment: what should we take into account - Variant calling and somatic mutation identification and prioritization on NGS data: an advanced overview - Using and combining the different tools for predicting the pathogenicity of sequence variants (PolyPhen, SIFT, etc)
  • 3. Overview of the Series NGS and the molecular basis of disease: a practical view. Ivo Gut, CNAG Data analysis pipelines for NGS applications Sergi Beltran, CNAG Interpretation of sequence variants in the clinical setting. Xavier de la Cruz, VHIR SESSION 1 (2h): FUNDAMENTALS 11. February 2015, 15:00-17:00 Data analysis pipelines for NGS applications Sophia Derdak, CNAG Interpretation: processing the output of bioinformatics tools. Casandra Riera, VHIR SESSION 2 (2h): TOOLS 18. February 2015, 15:00-17:00
  • 4. CNAG The CNAG is a non-profit organization created on 2010 and integrated in the Barcelona Science Park. It is funded by the Spanish Ministry of Economy and Competitiveness and the Catalan Government through the Economy and Knowledge Department and the Health Department (30M € initial funding, 2010- 2012). Competitive grants and contractual research with the private sector provide additional funds. Our Mission To carry out large-scale projects in genome analysis that will lead to significant improvements in people’s health and quality of life, in collaboration with the Catalan, Spanish, European and International research and clinical community. Our Vision To be a large-scale, high quality sequence analysis center and to be a world reference center for genomic analysis.
  • 5. Director Ivo Gut 1 Sequencing Department Marta Gut 1 Biorepository (1) Sample Preparation (9) Sequencing Production (4) Laboratory Support (3) Single Cell Genomics(2) Bioinformatics Analysis Sergi Beltran 1 Production Bioinformatics (3) Data Analysis (7) Bioinformatics Support (2) Bioinformatics Development Simon Heath 1 Statistical Genomics (7) Algorithm Development (4) Genome Biology Marc Marti-Renom 1 Structural Genomics (9) Comparative Genomics (1) Applied Genomics Ivo Gut Biomedical Genomics (4) Genome Assembly and Annotation (3) Population Genomics (1) Programme Manager Mònica Bayés 2 Administrative Support 3 Production Teams ResearchTeams CNAG Organigram 64 people 1 ICREA Research Professor 28 people funded or co-funded with personnel grants or competitive projects
  • 6. ICTS The CNAG becomes part of the National Scientific and Technological Infrastructure Map (ICTS): - Integrated Infrastructure for OMICS : - Plataforma de Metabolómica del Centro de Ciencias Ómicas (COS, Lluis Arola). - Centro Nacional de Análisis Genómico (CNAG, Ivo Gut) - Requires >20% of competitive access. Since 2014 researchers with large scale projects are required to submit an application that is reviewed by the Access Committee (constituted by CNAG director, Elías Campo, Pere Puigdoménech and Ángel Carracedo).
  • 7. The genomehenge Sequencing capacity • >1000 Gbases/day = 9-10 human genomes per day at 30x coverage Equipment • 11 Illumina HiSeq2000/2500/1T • 1 Illumina MiSeq • 4 Illumina cBots • 2 Oxford Nanopore Minions • Caliper/Eppendorf liquid handling robotics • Bull 1200 core cluster super computer • Maxeler Data Flow Engine • 25 Tflops • 2.7 petabyte disc space • Barcelona Supercomputing Center (10 x 10 Gb/s)
  • 8. How we work – Our process Biological Resources Sequencing Informatics - Reception - Quality control - Conditioning - Storage - Sample Preparation - Sequencing Production - Methods Development o Bioinformatic Analysis o Bioinformatic Development o Genome Biology o Applied Genomics LIMS + QC
  • 10. Sample preparation pipeline Whole genome shotgun sequencing no PCR, low input, FFPE, single cell Whole exome capture sequencing low input, FFPE Custom capture sequencing Amplicon sequencing Genotyping-by-sequencing RNA sequencing polyA selection, Ribo Zero selection, directional, low input, single cell Whole genome bisulphite sequencing regular and low input
  • 11.
  • 12.
  • 13.
  • 14. Informatics Resources Production Bioinformatics • Primary run analysis and verification • QC systems and LIMS Analysis Production • Alignment, variant calling and annotation • Analysis and interpretation Statistical Genomics • DNA methylation pipeline • RNA analysis pipeline de novo Assembly and Annotation • Pipeline for de novo assembly • Pipeline for genome annotation Algorithm Development • Development and improvement of alignment and assembly methods - GEM • Data compression Structural Genomics • Modelling of 3-d structure of genomes - HiC analysis Comparative Genomics Biomedical Genomics • Advanced data mining Population Genomics Databases • Storage and distribution of data
  • 15. Variant Calling Identification of genetic differences in comparison to a reference (strict definition) - Designs: Pedigree, trio, group, somatic
  • 16. Variant analysis example: stepwise filtering VCF Filtering parameters dbSNP dbCNAG Inheritance model Functional annotation Pedigree Multiple samples Somatic detection Shared vs non-shared Fisher test allele counts
  • 17. Variant analysis example: stepwise filtering VCF Filtering parameters dbSNP dbCNAG Inheritance model Functional annotation Pedigree Multiple samples Somatic detection Shared vs non-shared Fisher test allele counts
  • 18. CNAG is a major contributor and driver in three large International Initiatives: 1.- International Cancer Genome Consortium (ICGC) Spanish Project on Chronic Lymphocytic Leukaemia French Project on Prostate Cancer French Project on Ewing’s Sarcoma 2.- International Human Epigenome Consortium (IHEC) EU-funded Project Blueprint 3.- International Rare Disorders Research Consortium (IRDiRC) Spanish Project on Charcot-Marie-Tooth Disease EU-funded C-Project on data analysis and coordination What are our major projects?
  • 20. Nature 464, 993-998 (15.04.2010)
  • 21. Tumoral Non-Tumoral RNADNA methylationDNA peripheral peritumoral Whole-genome bisulphite seq Exome seq RNA seq Whole-genome seq short insert PE Sampling structure
  • 22. International Cancer Genome Consortium The International Cancer Genome Consortium is an international effort to establish a comprehensive description of genomic, transcriptomic and epigenomic changes in 50 different tumor types and/or subtypes which are of clinical and societal importance across the globe. Spain’s contribution to the ICGC is on chronic lymphocytic leukaemia (CLL). FUNDING SOURCE: Ministerio de Ciencia e Innovación COORDINATOR: Prof. Elias Campo, Hospital Clínic Barcelona DURATION: May 2009 – May 2014 PROJECT FUNDING: €10 million
  • 23. XS Puente et al. Nature 000, 1-5 (2011) doi:10.1038/nature10113 Mutational and functional analysis of NOTCH1 in CLL 5. June 2011
  • 24. • Sequencing of 105 CLL tumours • Identification of 1246 somatic mutations in 1.100 genes • 78 genes with mutations in more than one patient • Mutated genes cluster in pathways • Distinct mutations are associated with clinical classifications • Mutations in the SF3B1 gene identifies a group of patients with more aggressive disease • SF3B1 encodes a subunit of the spliceosomal U2 small nuclear ribonucleoprotein (snRNP) V Quesada et al. Nature Genetics 44, 47-52 (2011) doi:10.1038/ng1032
  • 25.
  • 27. Sample Prep Add unmethylated lambda DNA Bisulfite conversion qPCR check of conversion Sequencing Fully convert reads Alignment (GEM) QC (mapping, conversion) Select uniquely mapping read pairs Make genotype and methylation calls Select sites with genotype p.p. >=0.99 Select CpGs and non- CpGs Select homozygous CC or GG sites Region detection and annotation BS-Seq oxBS-Seq Merge to obtain estimates of mC and hmC levels BS-Sequencing Pipeline Statistical Genomics Team (S. Heath)
  • 28. • Distinct DNA methylomes of newborns and centenarians. Heyn et al. 2012 (PNAS) • Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Kulis et al. 2012 (Nat. Genetics) • Blueprint EU-FP7 project BS-Sequencing applications - Statistical Genomics Team (S. Heath)
  • 29.
  • 30.
  • 31. Proposed model for a different cell of origin of CLL subtypes (U-CLL from naive-like B cells and M-CLL from memory-like B cells) Naive B cell Leukemictransformation Activation Proliferation Differentiation Normal B cell differentiation 66% CpGs in common Memory B cell Plasma cell23,052 hypoM / 3,231 hyperM U-CLL M-CLL 4,607 hypoM 1,246 hyperM 3,265 diffM M Kulis et al. Nature Genetics 44, 1236-1242 (2012) doi:10.1038/ng2443
  • 32. Single-cell RNA-seq Cell isolation Library preparation Sequencing Data analysis
  • 33. Single-cell isolation methods • Laser capture micro-dissection (LCM) • Manual micro-pipetting (ICSI-like) • Fluorescent-activated cell sorting (FACS) • Microfluidic methods – C1 Single-cell AutoPrep System (Fluidigm) – Droplet-based microfluidics • Single-cell RNA-seq in context (in situ), no need for single-cell isolation
  • 34. • C1 Single-cell AutoPrep System (Fluidigm) Continuous-flow microfluidics Small cells: 5-10µm Medium cells: 10-17µm Large cells: 17-25µm www.fluidigm.com
  • 35. Library preparation Cell lysis Reverse transcription: 1st strand synthesis 2nd strand synthesis cDNA amplification Addition of adapters for sequencing Library amplification
  • 36. SMART-seq Image from www.clontech.com Ramsköld et al, Nature Biotech, 2012 Switching Mechanism At 5’ end of RNA Template Based on MMLV RTase properties: 1- Terminal transferase activity Adds non-templated Cs 2- Template switching activity (improves full-length capture) MMLV RT: Moloney murine leukemia virus reverse transcriptase (Oligo dT) 1 2
  • 37. Scatter plots (pairwise comparisons) Correlation is better for highly expressed genes Single cell 750 a,b,c excellent correlation although different libraries Worst correlation with debris
  • 39. Principal component analysis (- pool and debris)
  • 40. MARS-seq Jaitin et al, Science, 2014
  • 41. Collaborators 27 93 94 116 2 10 11 3 0 20 40 60 80 100 120 140 2011 2012 2013 2014 Collaborators by sector Public Private 3 20 31 2626 83 74 93 0 20 40 60 80 100 120 140 2011 2012 2013 2014 Collaborators by origin International National
  • 42. Sequencing applications and research area 2014 activity by sequencing application 2014 activity by research area 51,12% 21,75% 0,95% 26,19% Cancer Genomics Disease Gene Identification Infectious Disease Genomics Model-and Agro-Genomics 41,60% 25,08% 21,29% 9,13% 1,49% 0,84% 0,57% WG-Seq Exome-Seq RNA-Seq BS-Seq Custom Capture-Seq ChIP-Seq Genotyping by Seq
  • 43. 1st CNAG Call for Exome Sequencing in rare disorders – 2013/2014 The program has provided free-of- charge Whole Exome Sequencing and Bioinformatic analysis to the selected projects.  44 Applications received (941 exomes)  23 Projects selected by an External Selection Committee (345 exomes)  Confirmed causal variants in 3 families  Putative causal variants in 19 families
  • 44. How do we work with our collaborators? • Collaboration from study design to paper writing • Contact through the CNAG Project Manager (projectmanager-cnag@pcb.ub.es) or Fatima Nuñez • First point of discussion – advice on project • Agreement on project • Sample transfer using a standardized procedure (Lidia Agueda) • Sample preparation and sequencing (Marta Gut) • Data analysis (Sergi Beltran)
  • 45. It is like Ballet, - because it looks easy, everyone thinks it is easy.
  • 46. 26th February 2015 Auditori Antoni Caparrós Parc Científic de Barcelona Free online registration at: www.pcb.ub.edu/cnagevents
  • 47.
  • 48. Acknowledgements Ivo Gut Mònica Bayés Berta Fusté Diego Ravenda Katia López Anna Borrell Marta Gut Julie Blanc Katja Kahlem María Méndez-Lago Lidia Agueda Lidia Sevilla Javier Gutiérrez Aurora Padrón Gloria Plaja Marta López Pili Herruzo Bea Fontal Ana González Laetitia Casano Amaya Alzu Maite Rico Caterina Mata Amy Guillaumet Nicolas Boulanger Esther Lizano Simon Heath Sergi Beltran Marc A. Marti-Renom Tomas Marques Jordi Camps Jean-Rémi Trotta Emanuele Raineri Ron Schuyler Angelika Merkel Marc Dabad Justin Whalley Paolo Ribeca Tyler Alioto Leonor Frías Santiago Marco Lukasz Roguski Marcos Fernández Fernando Cruz Anna Esteve Davide Baú François Serra Sophia Derdak Steven Laurie Raul Tonda Enric Serra Francisco Martínez Mike Goodstadt Matt Ingham Colin Kingswood Raul Alcántara Meritxell Oliva Gian Andri Thun Gustavo Rodriguez-Esteban Miranda Stobbe
  • 49. baldiri reixac, 4 08028, barcelona spain t +34 93 4020542 f +34 93 4037279 www.cnag.eu